Clover Health Investments Corp. Statistics
Share Statistics
Clover Health Investments Corp. has 501.11M shares outstanding. The number of shares has increased by 25.31% in one year.
| Shares Outstanding | 501.11M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.21% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 458.83M |
| Failed to Deliver (FTD) Shares | 688 |
| FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 18.33M, so 3.66% of the outstanding shares have been sold short.
| Short Interest | 18.33M |
| Short % of Shares Out | 3.66% |
| Short % of Float | 4% |
| Short Ratio (days to cover) | 2.08 |
Valuation Ratios
The PE ratio is -2.15 and the forward PE ratio is -23.21.
| PE Ratio | -2.15 |
| Forward PE | -23.21 |
| PS Ratio | 0.23 |
| Forward PS | 1 |
| PB Ratio | 1.6 |
| P/FCF Ratio | -3.94 |
| PEG Ratio | n/a |
Enterprise Valuation
Clover Health Investments Corp. has an Enterprise Value (EV) of 340.88M.
| EV / Earnings | -1.6 |
| EV / Sales | 0.17 |
| EV / EBITDA | -1.62 |
| EV / EBIT | -1.63 |
| EV / FCF | -2.93 |
Financial Position
The company has a current ratio of 1.64, with a Debt / Equity ratio of 0.
| Current Ratio | 1.64 |
| Quick Ratio | 1.64 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | -29791.71 |
Financial Efficiency
Return on equity (ROE) is -0.74% and return on capital (ROIC) is -71.65%.
| Return on Equity (ROE) | -0.74% |
| Return on Assets (ROA) | -0.37% |
| Return on Capital (ROIC) | -71.65% |
| Revenue Per Employee | 3.68M |
| Profits Per Employee | -386.52K |
| Employee Count | 552 |
| Asset Turnover | 3.56 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 213.58% in the last 52 weeks. The beta is 2.04, so Clover Health Investments Corp.'s price volatility has been higher than the market average.
| Beta | 2.04 |
| 52-Week Price Change | 213.58% |
| 50-Day Moving Average | 3.68 |
| 200-Day Moving Average | 2.05 |
| Relative Strength Index (RSI) | 31.05 |
| Average Volume (20 Days) | 7.22M |
Income Statement
In the last 12 months, Clover Health Investments Corp. had revenue of $2.03B and earned -$213.36M in profits. Earnings per share was $-0.44.
| Revenue | 2.03B |
| Gross Profit | 257.33M |
| Operating Income | -208.54M |
| Net Income | -213.36M |
| EBITDA | -210.84M |
| EBIT | -208.54M |
| Earnings Per Share (EPS) | -0.44 |
Balance Sheet
The company has $122.86M in cash and $4.66M in debt, giving a net cash position of $118.20M.
| Cash & Cash Equivalents | 122.86M |
| Total Debt | 4.66M |
| Net Cash | 118.20M |
| Retained Earnings | -2.16B |
| Total Assets | 653.01M |
| Working Capital | 153.09M |
Cash Flow
In the last 12 months, operating cash flow was -$115.87M and capital expenditures -$584.00K, giving a free cash flow of -$116.45M.
| Operating Cash Flow | -115.87M |
| Capital Expenditures | -584.00K |
| Free Cash Flow | -116.45M |
| FCF Per Share | -0.24 |
Margins
Gross margin is 12.65%, with operating and profit margins of -10.25% and -10.49%.
| Gross Margin | 12.65% |
| Operating Margin | -10.25% |
| Pretax Margin | -10.49% |
| Profit Margin | -10.49% |
| EBITDA Margin | -10.37% |
| EBIT Margin | -10.25% |
| FCF Margin | -5.73% |
Dividends & Yields
CLOV does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -14.24% |
| FCF Yield | -7.52% |
Analyst Forecast
The average price target for CLOV is $4, which is 29.4% higher than the current price. The consensus rating is "Hold".
| Price Target | $4 |
| Price Target Difference | 29.4% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
Scores
| Altman Z-Score | 0.5 |
| Piotroski F-Score | 3 |